92 related articles for article (PubMed ID: 2102359)
1. Defining the structural requirements of a biologically active domain of human IL-1 beta.
Boraschi D; Antoni G; Perin F; Villa L; Nencioni L; Ghiara P; Presentini R; Tagliabue A
Eur Cytokine Netw; 1990; 1(1):21-6. PubMed ID: 2102359
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.
Boraschi D; Volpini G; Villa L; Nencioni L; Scapigliati G; Nucci D; Antoni G; Matteucci G; Cioli F; Tagliabue A
J Immunol; 1989 Jul; 143(1):131-4. PubMed ID: 2786529
[TBL] [Abstract][Full Text] [Related]
3. Defining agonist peptides of human interleukin-1 beta.
Tagliabue A; Antoni G; Boraschi D
Lymphokine Res; 1989; 8(3):311-5. PubMed ID: 2789323
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants.
Boraschi D; Tagliabue A
Methods; 1999 Sep; 19(1):108-13. PubMed ID: 10525446
[TBL] [Abstract][Full Text] [Related]
5. Human interleukin 1: structure-function relationship.
Boraschi D; Tagliabue A
Ann Ist Super Sanita; 1990; 26(3-4):273-82. PubMed ID: 2091500
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routes.
Nencioni L; Villa L; Tagliabue A; Boraschi D
Lymphokine Res; 1987; 6(4):335-9. PubMed ID: 3501509
[TBL] [Abstract][Full Text] [Related]
7. Increasing the immunogenicity of protein antigens through the genetic insertion of VQGEESNDK sequence of human IL-1 beta into their sequence.
Beckers W; Villa L; Gonfloni S; Castagnoli L; Newton SM; Cesareni G; Ghiara P
J Immunol; 1993 Aug; 151(4):1757-64. PubMed ID: 8345181
[TBL] [Abstract][Full Text] [Related]
8. A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity.
Antoni G; Presentini R; Perin F; Tagliabue A; Ghiara P; Censini S; Volpini G; Villa L; Boraschi D
J Immunol; 1986 Nov; 137(10):3201-4. PubMed ID: 3490514
[TBL] [Abstract][Full Text] [Related]
9. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
[TBL] [Abstract][Full Text] [Related]
10. Radioprotection by N-palmitoylated nonapeptide of human interleukin-1beta.
Singh VK; Srinivasan V; Seed TM; Jackson WE; Miner VE; Sree Kumar K
Peptides; 2005 Mar; 26(3):413-8. PubMed ID: 15652647
[TBL] [Abstract][Full Text] [Related]
11. Radiation protection and restoration by the synthetic 163-171 nonapeptide of human interleukin 1 beta.
Frasca D; Baschieri S; Boraschi D; Tagliabue A; Doria G
Radiat Res; 1991 Oct; 128(1):43-7. PubMed ID: 1924727
[TBL] [Abstract][Full Text] [Related]
12. In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.
Nencioni L; Villa L; Tagliabue A; Antoni G; Presentini R; Perin F; Silvestri S; Boraschi D
J Immunol; 1987 Aug; 139(3):800-4. PubMed ID: 2955051
[TBL] [Abstract][Full Text] [Related]
13. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
14. The immunostimulatory effect of IL-1beta in vivo is blocked by antisense peptides complementary to the loop sequence 163-171.
Boraschi D; Tagliabue A; Miller AD
FEBS Lett; 2009 Feb; 583(4):792-6. PubMed ID: 19185574
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-inducing activity of a proline-rich polypeptide complex (PRP) from ovine colostrum and its active nonapeptide fragment analogs.
Zabłocka A; Janusz M; Rybka K; Wirkus-Romanowska I; Kupryszewski G; Lisowski J
Eur Cytokine Netw; 2001; 12(3):462-7. PubMed ID: 11566627
[TBL] [Abstract][Full Text] [Related]
16. In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice.
Frasca D; Boraschi D; Baschieri S; Bossu P; Tagliabue A; Adorini L; Doria G
J Immunol; 1988 Oct; 141(8):2651-5. PubMed ID: 2971727
[TBL] [Abstract][Full Text] [Related]
17. Identification of distinct sites of beta-endorphin that stimulate lymphokine production by murine CD4+ T cells.
Van den Bergh P; Rozing J; Nagelkerken L
Lymphokine Cytokine Res; 1994 Apr; 13(2):63-9. PubMed ID: 7914752
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice.
Forni G; Musso T; Jemma C; Boraschi D; Tagliabue A; Giovarelli M
J Immunol; 1989 Jan; 142(2):712-8. PubMed ID: 2463312
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies of human IL-1 beta with mature and truncated proteins expressed in Escherichia coli.
Lillquist JS; Simon PL; Summers M; Jonak Z; Young PR
J Immunol; 1988 Sep; 141(6):1975-81. PubMed ID: 3049798
[TBL] [Abstract][Full Text] [Related]
20. The 163-171 peptide of human IL-1 beta.
Boraschi D; Ghiara P; Villa L; Antoni G; Tagliabue A
Prog Clin Biol Res; 1990; 349():365-74. PubMed ID: 2144645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
